Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
This study has been completed.
Information provided by (Responsible Party):
First received: May 3, 2002
Last updated: May 7, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2004|
|Primary Completion Date:||February 2004 (Final data collection date for primary outcome measure)|
Vogel CL, Wojtukiewicz MZ, Carroll RR, Tjulandin SA, Barajas-Figueroa LJ, Wiens BL, Neumann TA, Schwartzberg LS. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol. 2005 Feb 20;23(6):1178-84.